Europe Polio Vaccine Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

    The Polio Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.0% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Polio Vaccine Market Segmentations:

    By Player:

    • Halfkin Bio-Pharmaceuticals

    • Bio-Med

    • GSK

    • Bibcol

    • Tiantan Biological

    • Sanofi

    • Serum Institute

    • Panacea Biotec Ltd

    • IMBCA

    By Type:

    • Inactivated Polio Vaccine (IPV)

    • Oral Polio Vaccine (OPV)

    By End-User:

    • Public

    • Private

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Polio Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Polio Vaccine Market Size and Growth Rate of Inactivated Polio Vaccine (IPV) from 2014 to 2026

    • 1.3.2 Europe Polio Vaccine Market Size and Growth Rate of Oral Polio Vaccine (OPV) from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Polio Vaccine Market Size and Growth Rate of Public from 2014 to 2026

    • 1.4.2 Europe Polio Vaccine Market Size and Growth Rate of Private from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Polio Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Polio Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Polio Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Polio Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Polio Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Polio Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Polio Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Polio Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Polio Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Polio Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Polio Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Inactivated Polio Vaccine (IPV)

      • 3.4.2 Market Size and Growth Rate of Oral Polio Vaccine (OPV)

    4 Segmentation of Polio Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Polio Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Public for Construction

      • 4.4.2 Market Size and Growth Rate of Private for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Polio Vaccine Production Analysis by Top Regions

    • 5.2 Europe Polio Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Polio Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Polio Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Polio Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Polio Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Polio Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Polio Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Polio Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Polio Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Polio Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Polio Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Polio Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Polio Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Polio Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Polio Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Polio Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Polio Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Polio Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Polio Vaccine Landscape Analysis

    • 7.1 Germany Polio Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Polio Vaccine Landscape Analysis by Major End-Users

    8. UK Polio Vaccine Landscape Analysis

    • 8.1 UK Polio Vaccine Landscape Analysis by Major Types

    • 8.2 UK Polio Vaccine Landscape Analysis by Major End-Users

    9. France Polio Vaccine Landscape Analysis

    • 9.1 France Polio Vaccine Landscape Analysis by Major Types

    • 9.2 France Polio Vaccine Landscape Analysis by Major End-Users

    10. Italy Polio Vaccine Landscape Analysis

    • 10.1 Italy Polio Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Polio Vaccine Landscape Analysis by Major End-Users

    11. Spain Polio Vaccine Landscape Analysis

    • 11.1 Spain Polio Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Polio Vaccine Landscape Analysis by Major End-Users

    12. Poland Polio Vaccine Landscape Analysis

    • 12.1 Poland Polio Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Polio Vaccine Landscape Analysis by Major End-Users

    13. Russia Polio Vaccine Landscape Analysis

    • 13.1 Russia Polio Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Polio Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Polio Vaccine Landscape Analysis

    • 14.1 Switzerland Polio Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Polio Vaccine Landscape Analysis by Major End-Users

    15. Turkey Polio Vaccine Landscape Analysis

    • 15.1 Turkey Polio Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Polio Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Polio Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Polio Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Polio Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Polio Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Polio Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Polio Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Polio Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Polio Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Polio Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Polio Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Polio Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Halfkin Bio-Pharmaceuticals

      • 19.1.1 Halfkin Bio-Pharmaceuticals Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Bio-Med

      • 19.2.1 Bio-Med Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 GSK

      • 19.3.1 GSK Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Bibcol

      • 19.4.1 Bibcol Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Tiantan Biological

      • 19.5.1 Tiantan Biological Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Sanofi

      • 19.6.1 Sanofi Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Serum Institute

      • 19.7.1 Serum Institute Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Panacea Biotec Ltd

      • 19.8.1 Panacea Biotec Ltd Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 IMBCA

      • 19.9.1 IMBCA Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    The List of Tables and Figures (Totals 87 Figures and 144 Tables)

    • Figure Product Picture

    • Figure Polio Vaccine Market Size and Growth Rate of Inactivated Polio Vaccine (IPV) Market, 2015 - 2026 (USD Million)

    • Figure Polio Vaccine Market Size and Growth Rate of Oral Polio Vaccine (OPV) Market, 2015 - 2026 (USD Million)

    • Figure Polio Vaccine Market Size and Growth Rate of Public from 2014 to 2026

    • Figure Polio Vaccine Market Size and Growth Rate of Private from 2014 to 2026

    • Figure Germany Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Polio Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Polio Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Polio Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Polio Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Polio Vaccine by Different Types from 2014 to 2026

    • Figure Polio Vaccine Market Size and Growth Rate of Inactivated Polio Vaccine (IPV) Market, 2015 - 2026 (USD Million)

    • Figure Polio Vaccine Market Size and Growth Rate of Oral Polio Vaccine (OPV) Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Polio Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Polio Vaccine by Different End-Users from 2014 to 2026

    • Figure Polio Vaccine Market Size and Growth Rate of Public from 2014 to 2026

    • Figure Polio Vaccine Market Size and Growth Rate of Private from 2014 to 2026

    • Table Europe Polio Vaccine Production by Major Regions

    • Table Europe Polio Vaccine Production Share by Major Regions

    • Figure Europe Polio Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Polio Vaccine Consumption by Major Regions

    • Table Europe Polio Vaccine Consumption Share by Major Regions

    • Table Germany Polio Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Polio Vaccine Production, Import, Consumption and Export Analysis

    • Table France Polio Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Polio Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Polio Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Polio Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Polio Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Polio Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Polio Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Polio Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Polio Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Polio Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Polio Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Polio Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Polio Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Polio Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Polio Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Polio Vaccine Consumption by Types from 2014 to 2026

    • Table UK Polio Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Polio Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Polio Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Polio Vaccine Consumption by Types from 2014 to 2026

    • Table France Polio Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Polio Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Polio Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Polio Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Polio Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Polio Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Polio Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Polio Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Polio Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Polio Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Polio Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Polio Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Polio Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Polio Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Polio Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Polio Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Polio Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Polio Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Polio Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Polio Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Polio Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Polio Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Polio Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Polio Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Polio Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Polio Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Polio Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Polio Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Polio Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Polio Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Polio Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Polio Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Polio Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Polio Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Polio Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Polio Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Polio Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Polio Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Polio Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Polio Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Polio Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Halfkin Bio-Pharmaceuticals Profiles

    • Table Halfkin Bio-Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Halfkin Bio-Pharmaceuticals Product benchmarking

    • Table Halfkin Bio-Pharmaceuticals Strategic initiatives

    • Table Halfkin Bio-Pharmaceuticals SWOT analysis

    • Table Bio-Med Profiles

    • Table Bio-Med Production, Value, Price, Gross Margin 2014-2019

    • Table Bio-Med Product benchmarking

    • Table Bio-Med Strategic initiatives

    • Table Bio-Med SWOT analysis

    • Table GSK Profiles

    • Table GSK Production, Value, Price, Gross Margin 2014-2019

    • Table GSK Product benchmarking

    • Table GSK Strategic initiatives

    • Table GSK SWOT analysis

    • Table Bibcol Profiles

    • Table Bibcol Production, Value, Price, Gross Margin 2014-2019

    • Table Bibcol Product benchmarking

    • Table Bibcol Strategic initiatives

    • Table Bibcol SWOT analysis

    • Table Tiantan Biological Profiles

    • Table Tiantan Biological Production, Value, Price, Gross Margin 2014-2019

    • Table Tiantan Biological Product benchmarking

    • Table Tiantan Biological Strategic initiatives

    • Table Tiantan Biological SWOT analysis

    • Table Sanofi Profiles

    • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

    • Table Sanofi Product benchmarking

    • Table Sanofi Strategic initiatives

    • Table Sanofi SWOT analysis

    • Table Serum Institute Profiles

    • Table Serum Institute Production, Value, Price, Gross Margin 2014-2019

    • Table Serum Institute Product benchmarking

    • Table Serum Institute Strategic initiatives

    • Table Serum Institute SWOT analysis

    • Table Panacea Biotec Ltd Profiles

    • Table Panacea Biotec Ltd Production, Value, Price, Gross Margin 2014-2019

    • Table Panacea Biotec Ltd Product benchmarking

    • Table Panacea Biotec Ltd Strategic initiatives

    • Table Panacea Biotec Ltd SWOT analysis

    • Table IMBCA Profiles

    • Table IMBCA Production, Value, Price, Gross Margin 2014-2019

    • Table IMBCA Product benchmarking

    • Table IMBCA Strategic initiatives

    • Table IMBCA SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.